Upload
elwin-patterson
View
220
Download
2
Embed Size (px)
Citation preview
By : Zach Weiss, Tiffany Maestas & Amanda LopezPresented to: Dr. ToolsonBiology 445 April 21, 2010
By : Zach Weiss, Tiffany Maestas & Amanda LopezPresented to: Dr. ToolsonBiology 445 April 21, 2010
The Malayan (Blue) Krait is a highly venomous elapid snake, and is one of 12 species of kraits in the Bungarus genus.
3rd deadliest snake in the world
We will discuss…We will discuss…
• Distribution• Habitat• Reproduction• Diet and
Behavior• Venom
• Distribution• Habitat• Reproduction• Diet and
Behavior• Venom
Where are they found?Where are they found?
Southeast Asia… • Thailand• Cambodia• Vietnam• Malaysia• Singapore• Indonesia
Southeast Asia… • Thailand• Cambodia• Vietnam• Malaysia• Singapore• Indonesia
HabitatHabitatHabitatHabitat
• Flat and hilly countryFlat and hilly country• Found in areas at heights Found in areas at heights
of 2300 metersof 2300 meters• In habit open areas, In habit open areas,
fields, grassy landscapes, fields, grassy landscapes, and forestsand forests
• Sometimes found in close Sometimes found in close proximity to waterproximity to water
• Avoid the sun, so found Avoid the sun, so found under fallen down trees or under fallen down trees or rotting stumps rotting stumps
• Flat and hilly countryFlat and hilly country• Found in areas at heights Found in areas at heights
of 2300 metersof 2300 meters• In habit open areas, In habit open areas,
fields, grassy landscapes, fields, grassy landscapes, and forestsand forests
• Sometimes found in close Sometimes found in close proximity to waterproximity to water
• Avoid the sun, so found Avoid the sun, so found under fallen down trees or under fallen down trees or rotting stumps rotting stumps
• OviparousOviparous – lay eggs– lay eggs
• Mating season - March and AprilMating season - March and April
• Female lays 4 to 10 eggs - 2 months after Female lays 4 to 10 eggs - 2 months after mating seasonmating season
• The females remain with their eggs until The females remain with their eggs until they have hatched and guard themthey have hatched and guard them
• Incubation period of the eggs: 60-64 daysIncubation period of the eggs: 60-64 days
• The newborns are between 30 to 32 cm The newborns are between 30 to 32 cm longlong
• OviparousOviparous – lay eggs– lay eggs
• Mating season - March and AprilMating season - March and April
• Female lays 4 to 10 eggs - 2 months after Female lays 4 to 10 eggs - 2 months after mating seasonmating season
• The females remain with their eggs until The females remain with their eggs until they have hatched and guard themthey have hatched and guard them
• Incubation period of the eggs: 60-64 daysIncubation period of the eggs: 60-64 days
• The newborns are between 30 to 32 cm The newborns are between 30 to 32 cm longlong
Venom!Venom!Venom!Venom!Extremely potent neurotoxic venom
You do not want to mess with this snake!
Extremely potent neurotoxic venom
You do not want to mess with this snake!
B. candidus VenomB. candidus Venom
• Neurotoxic• 16 times more potent than cobra venom• LD50=3.5 μg (mice)• Venom is very powerful and quickly
induces muscle paralysis• Venom contain mostly pre-synaptic
neurotoxins• Effect the ability of neuron endings to
properly release the chemical that sends the message to the next neuron
• Neurotoxic• 16 times more potent than cobra venom• LD50=3.5 μg (mice)• Venom is very powerful and quickly
induces muscle paralysis• Venom contain mostly pre-synaptic
neurotoxins• Effect the ability of neuron endings to
properly release the chemical that sends the message to the next neuron
B. candidus Venom Effects
B. candidus Venom Effects
• Frequently little or no pain at site of krait bite
• Leads to massive overexcitation, cramps, tremors, spasms, eventually inducing paralysis
• Cause of death if often respiratory failure due to paralysis of diaphragm (usually occurs 6-12 hours after bite
• Most bites occur at night since the snake is nocturnal
• Frequently little or no pain at site of krait bite
• Leads to massive overexcitation, cramps, tremors, spasms, eventually inducing paralysis
• Cause of death if often respiratory failure due to paralysis of diaphragm (usually occurs 6-12 hours after bite
• Most bites occur at night since the snake is nocturnal
• Target nerve cells (neurons)• Snake neurotoxins especially like
to target the motor neurons of the Peripheral Nervous System
• Inhibit proper neuron function• Neuron inhibition causes paralysis.• Death usually occurs by asphyxia
due to respiratory faiure.
• Target nerve cells (neurons)• Snake neurotoxins especially like
to target the motor neurons of the Peripheral Nervous System
• Inhibit proper neuron function• Neuron inhibition causes paralysis.• Death usually occurs by asphyxia
due to respiratory faiure.
NeurotoxinsNeurotoxins
• Snake neurotoxins target the motor neurons of the peripheral nervous system and can act presynaptically, postsynaptically, or both.
• Presynaptically acting neurotoxins are called β-neurotoxins
• Postsynaptically acting neurotoxins are called Alpha-neurotoxins
• Snake neurotoxins target the motor neurons of the peripheral nervous system and can act presynaptically, postsynaptically, or both.
• Presynaptically acting neurotoxins are called β-neurotoxins
• Postsynaptically acting neurotoxins are called Alpha-neurotoxins
NeurotoxinsNeurotoxins
• Snake neurotoxins specifically target the neuromuscular junctions in the peripheral nervous system and block neuromuscular transmission, either presynaptically or postsynaptically, leading to muscle paralysis
• Snake neurotoxins specifically target the neuromuscular junctions in the peripheral nervous system and block neuromuscular transmission, either presynaptically or postsynaptically, leading to muscle paralysis
Neuromuscular JunctionNeuromuscular JunctionNeuromuscular JunctionNeuromuscular Junction
The Neuromuscular Junction
Three-Finger Toxin Family
Three-Finger Toxin Family
Candotoxin, a novel three-finger toxin from the Bungarus candidus
Bungarus candidus venom contains several toxins of the three finger toxin family
Three-finger Toxin Family
Three-finger Toxin Family
• Three-finger toxins exhibit a broad range of pharmacological activity:• Central and Peripheral neurotoxicty • Cytotoxicity• Cardiotoxicity• Inhibition of enzymes such as
acetylcholinesterase • Platelet aggregation
• Three-finger toxins exhibit a broad range of pharmacological activity:• Central and Peripheral neurotoxicty • Cytotoxicity• Cardiotoxicity• Inhibition of enzymes such as
acetylcholinesterase • Platelet aggregation
Three-Finger Toxin Family
Three-Finger Toxin Family
• The three-finger toxin family is a very diverse group of non-enzymatic polypeptides found only in the venom of elapid snakes
• Family includes a large variety of toxins with different functional activities that target different biological sites.
• The three-finger toxin family is a very diverse group of non-enzymatic polypeptides found only in the venom of elapid snakes
• Family includes a large variety of toxins with different functional activities that target different biological sites.
General three finger toxin structure
Three-Finger Toxin FamilyThree-Finger Toxin Family
Common structure of several three finger toxins including α-bungarotoxin (B) and candoxin (E) from B. candidusvenom, which will be discussed further.
Three-Finger Toxin Family
Three-Finger Toxin Family
• All the proteins of this family have a similar structure, but exhibit very different biological activity.
• Three finger toxin polypeptides contain 60-74 amino acid residues
• Contain several disulfide bonds (all three finger toxins have at least 4)
• All toxins share a common pattern of folding that has three loops extending from a central core.
• They have the structural appearance of “three fingers”
• All the proteins of this family have a similar structure, but exhibit very different biological activity.
• Three finger toxin polypeptides contain 60-74 amino acid residues
• Contain several disulfide bonds (all three finger toxins have at least 4)
• All toxins share a common pattern of folding that has three loops extending from a central core.
• They have the structural appearance of “three fingers”
Structural comparison of three finger toxins bucadin (orange) and bungarotoxin (purple) from B. candidus venom. Note differences in loop regions, which ultimately lead to differences in action of toxin.
Three-Finger Toxin FamilyThree-Finger Toxin Family
What’s in Snake Venom?
What’s in Snake Venom?
• It is highly modified saliva• Mostly comprised of proteins, enzymes,
substances with cytotoxic effect, neurotoxins, and coagulants
• Has about 20 different enzymes, of which, a species usually has between 6 and 12
• The enzymes determine the toxicity of the venom
• Venom’s primary importance is to capture or kill its prey then to help it digest its prey
• It is highly modified saliva• Mostly comprised of proteins, enzymes,
substances with cytotoxic effect, neurotoxins, and coagulants
• Has about 20 different enzymes, of which, a species usually has between 6 and 12
• The enzymes determine the toxicity of the venom
• Venom’s primary importance is to capture or kill its prey then to help it digest its prey
Components of Components of B. B. candidus candidus VenomVenom
Components of Components of B. B. candidus candidus VenomVenom
3 types of neurotoxins in Bungarus candidus:
• Candoxin: Novel three finger toxin from B. candidus
• Bucandin toxin: Novel presynaptic neurotoxin isolated from B. candidus
• Bungarotoxin: three finger toxin found in Elapid snake venom
3 types of neurotoxins in Bungarus candidus:
• Candoxin: Novel three finger toxin from B. candidus
• Bucandin toxin: Novel presynaptic neurotoxin isolated from B. candidus
• Bungarotoxin: three finger toxin found in Elapid snake venom
CandoxinCandoxin
Is a novel toxin in B. candidus venom
•Classified as a three finger toxin•Classified as a weak toxin•Its affects are reversible
•Candoxin is a postsynaptic neurotoxin•It shares similarities to α-neurotoxins, but has some important differences
Candoxin protein folded structure
Amino Acid residues in Candoxin
Candoxin Candoxin• Produces a reversible postjunctional
neuromuscular blockade by binding with muscle (αβγδ) receptors of the neuromuscular junction and α7 neuronal receptors.
• Produces a reversible postjunctional neuromuscular blockade by binding with muscle (αβγδ) receptors of the neuromuscular junction and α7 neuronal receptors.
Nicotinic Acetylcholine receptor
• Candoxin binding prevents acetylcholine from binding to the postsynaptic nicotinic acetylcholine receptors
• The action potential from the presynaptic neuron is blocked, preventing muscles from contracting
• This leads to muscle paralysis.
CandoxinCandoxin
Neuromuscular Junction
CandoxinCandoxin
Candoxin: •Binds reversibly to nicotinic acetylcholine receptors in the neuromuscular junction•Its fifth disulfide bridge is located at the tip of loop I
α-Neurotoxins:•Bind irreversibly to nicotinic acetylcholine receptors in the neuromuscular junction •Its fifth disulfide bridge is located at the tip of loop II
BucandinBucandinBucandinBucandin
• Classified as a three finger toxin• A novel presynaptic neurotoxin
• 63 amino acid polypeptide• 2 Antiparallel β-Sheets• Has a fourth strand in second antiparallel
β-Sheet• 5 dusulfide bonds• Shares only 30-40% similarity with most
three finger toxins
• Classified as a three finger toxin• A novel presynaptic neurotoxin
• 63 amino acid polypeptide• 2 Antiparallel β-Sheets• Has a fourth strand in second antiparallel
β-Sheet• 5 dusulfide bonds• Shares only 30-40% similarity with most
three finger toxins
Is a novel neurotoxin in B. candidus venom
Bucandin (A) protein structure compared to α-neurotoxins cobratoxin (B), erabutoxin (C), and cytotoxin II (D)
Bucandin amino acid sequence and disulfide-bonding pattern
BucandinBucandinBucandinBucandin•Enhances presynaptic acetylcholine release from the synaptic bulb.
•Bucandin causes excessive acetylcholine to be released into the synapse of the neuromuscular junction
•Excess acetylcholine in the synapse cannot be degraded by acetylcholinesterase
***The mechanism of Bucandin presynaptic action to cause excess acetylcholine release is unknown
Neuromuscular Junction
BucandinBucandin•The large increase in acetylcholine in the neuromuscular junction overwhelms the acetylcholine receptors and cause over-excitation of the skeletal muscles.
•Over-excitation of skeletal muscles leads to muscle spasms, tremors, seizures, etc.
•Ultimately, paralysis is induced.
Surface plot of Bucandin – amino acid residues with potential functional relevance are marked
BungarotoxinsBungarotoxinsBungarotoxinsBungarotoxins
Three-dimensional structure of α-bungarotoxin
BungarotoxinsBungarotoxins
α-bungarotoxins• Component of the
venom of the elapid krait snakes
• Acts postsynaptically• Binds irreversibly and
competitively to the acetylcholine receptor found in neuromuscular junction
• Causes paralysis, respiratory failure, and death
• A selective antagonist of the nicotinic acetylcholine receptor in the brain
α-bungarotoxins• Component of the
venom of the elapid krait snakes
• Acts postsynaptically• Binds irreversibly and
competitively to the acetylcholine receptor found in neuromuscular junction
• Causes paralysis, respiratory failure, and death
• A selective antagonist of the nicotinic acetylcholine receptor in the brain
β-bungarotoxins• Fairly common in some
snake venoms• Acts presynaptically• Alters acetylcholine
release in presynaptic terminal in both peripheral and central nervous systems
β-bungarotoxins• Fairly common in some
snake venoms• Acts presynaptically• Alters acetylcholine
release in presynaptic terminal in both peripheral and central nervous systems
BungarotoxinsBungarotoxins
B. Candidus venon contains α-bungarotoxins
•A three fingered toxin•Is a postsynaptic neurotoxin
•74 amino acid polypeptide
α-bungarotoxinstructure
BungarotoxinsBungarotoxinsBungarotoxinsBungarotoxins
• α-bungarotoxin binds postsynaptically in the neuromuscular junction to nicotinic acetylcholine receptors
• α-bungarotoxin binds with very high affinity and specificity for the acetycholine receptor
• α-bungarotoxin binds postsynaptically in the neuromuscular junction to nicotinic acetylcholine receptors
• α-bungarotoxin binds with very high affinity and specificity for the acetycholine receptor
nicotinic acetylcholine receptors
BungarotoxinsBungarotoxins•α-bungarotoxin binding prevents acetylcholine from binding to the nicotinic acetylcholine receptors on the postsynaptic side of the neuromuscular junction.
•The inability of acetylcholine to bind to its receptors prevents sodium channels from opening in the receptors.
•The action potential from the presynaptic neuron is blocked and muscle contraction is inhibited.
•This leads to muscle paralysis. Neuromuscular Junction
B. candidus B. candidus Attacks!Attacks! B. candidus B. candidus Attacks!Attacks!
• B. candidus bites are very rare.• They occur mostly in rural areas.• Bites occur mostly at night, since the
snake is nocturnal.• Death occurs quickly due to the extremely
high lethal toxicity and the neurotoxic mechanism of its venom.
• Fatalities from bites are underreported because most bites occur in rural areas and hospitals are too far away to treat patients in time.
• Frequently little or no pain at site of bite
• B. candidus bites are very rare.• They occur mostly in rural areas.• Bites occur mostly at night, since the
snake is nocturnal.• Death occurs quickly due to the extremely
high lethal toxicity and the neurotoxic mechanism of its venom.
• Fatalities from bites are underreported because most bites occur in rural areas and hospitals are too far away to treat patients in time.
• Frequently little or no pain at site of bite
Venom Extraction (milking)
Venom Extraction (milking)
How to Make Anti-venom
How to Make Anti-venom
• Milk the snake (make sure it has venom in it)• Inoculate a horse (or other animal) and let it build
up antibodies to the venom• Collect your horse serum with antibodies against
the toxins in the venom• Make sure your batch of anti-venom is injected
into infected blood stream within an hour, if not, you could be too late
• WARNING: Anti-venom only blocks further damage, it can’t undo what has already been done
• SIDE EFFECTS: Could cause an allergic reaction (i.e. serum sickness from the horse proteins)
• Milk the snake (make sure it has venom in it)• Inoculate a horse (or other animal) and let it build
up antibodies to the venom• Collect your horse serum with antibodies against
the toxins in the venom• Make sure your batch of anti-venom is injected
into infected blood stream within an hour, if not, you could be too late
• WARNING: Anti-venom only blocks further damage, it can’t undo what has already been done
• SIDE EFFECTS: Could cause an allergic reaction (i.e. serum sickness from the horse proteins)
Anti-venom Anti-venom
• Before anti-venom was developed there was an 85% mortality rate
• Mortality rate of 50% even with anti-venom
• The polyvalent Elapid anti-venom usually neutralizes effects
• If transport to medical care takes long a permanent coma and brain death from hypoxia can occur
• Before anti-venom was developed there was an 85% mortality rate
• Mortality rate of 50% even with anti-venom
• The polyvalent Elapid anti-venom usually neutralizes effects
• If transport to medical care takes long a permanent coma and brain death from hypoxia can occur
Medical Value of Snake Venom
Medical Value of Snake Venom
• Some snake venoms may slow the growth of cancerous tumors
• Snakes use venom to alter biological functions which is similar to the action of medications
• ACE inhibitors, a class of drugs used to treat high blood pressure and other cardiovascular disorders, were developed from the venom of a Brazilian snake
• The variations between venom types and the number of venomous snakes worldwide create a rich molecular hunting ground for researchers, seeking to find new drugs
• The advantage of these venom-derived toxins is that they seem to act only on certain types of cells
• Some snake venoms may slow the growth of cancerous tumors
• Snakes use venom to alter biological functions which is similar to the action of medications
• ACE inhibitors, a class of drugs used to treat high blood pressure and other cardiovascular disorders, were developed from the venom of a Brazilian snake
• The variations between venom types and the number of venomous snakes worldwide create a rich molecular hunting ground for researchers, seeking to find new drugs
• The advantage of these venom-derived toxins is that they seem to act only on certain types of cells
Medical Value of Snake Venom (cont.)
Medical Value of Snake Venom (cont.)
• Exanta, a blood thinner derived from the venom of the cobra manages to thin the blood at a steady level without major fluctuations
• Contortrostatin, a component found in copperhead venom, is being used to attack breast cancer cells and to prevent cancer from spreading
• A South American snake farm is harvesting venom to make homeopathic medicine for AIDS patients.
• Amazingly, snake venoms may also hold cures to many human diseases. Scientists have discovered that natural poisons, toxins, and venoms contain chemicals that can be used to create an array of drugs for treating everything from chronic pain to cancer
• Exanta, a blood thinner derived from the venom of the cobra manages to thin the blood at a steady level without major fluctuations
• Contortrostatin, a component found in copperhead venom, is being used to attack breast cancer cells and to prevent cancer from spreading
• A South American snake farm is harvesting venom to make homeopathic medicine for AIDS patients.
• Amazingly, snake venoms may also hold cures to many human diseases. Scientists have discovered that natural poisons, toxins, and venoms contain chemicals that can be used to create an array of drugs for treating everything from chronic pain to cancer
Medical Value of B. candidus Venom
Medical Value of B. candidus Venom
• The B. candidus snake is one of the medically significant snakes in Southeast Asia
• The most obvious medical use of B. candidus venom is to make anti-venom for snake bite victims
• Neurotoxic proteins are isolated from the venom and used as pharmacological tools to further research the function of the nervous system
• In minimal amounts it could possibly be used to bring about neuromuscular blockade like botulinum toxin
• The B. candidus snake is one of the medically significant snakes in Southeast Asia
• The most obvious medical use of B. candidus venom is to make anti-venom for snake bite victims
• Neurotoxic proteins are isolated from the venom and used as pharmacological tools to further research the function of the nervous system
• In minimal amounts it could possibly be used to bring about neuromuscular blockade like botulinum toxin
SummarySummary
The significance of our presentation:
The B. candidus species produces highly toxic venom• Consists of three types of toxins
1. Candoxin2. Bucandin3. α-bungarotoxin
• Mechanism of Action of the three toxins• Neurotoxic
• All three toxins belong to the three-finger toxin family• Anti-venom is hard to obtain due to rare occurrence of
bites• There are several medical uses of B. candidus venom
The significance of our presentation:
The B. candidus species produces highly toxic venom• Consists of three types of toxins
1. Candoxin2. Bucandin3. α-bungarotoxin
• Mechanism of Action of the three toxins• Neurotoxic
• All three toxins belong to the three-finger toxin family• Anti-venom is hard to obtain due to rare occurrence of
bites• There are several medical uses of B. candidus venom
Thank You!
SourcesSourcesFry, B.G., Wuster, W., Kini,R.M., Brusic, V., Khan, A.,
Venkataraman, D.,& Rooney, A.P. 2003. Molecular Evolution and Phylogeny of Elapid Snake Venom and Three-Finger Toxins. Journal of Molecular Evolution. 57:110-129.
Khow, O. Chanhome, L., Omori-Satoh, T., Ogawa, Y., Yanoshita, R., Samejima, Y., Kuch, U., Mebs, D., & Sitprija, V. 2003. Isolation, Toxicity and Amino Terminal Sequences of Three Major Neurotoxins in the Venom of Malayan Krait (Bungarus candidus) from Thailand. Journal of Biochemistry.134: 799-804.
Kuch, U., Molles, B.E., Satoh, T.O., Chanhome, L., Samejima , Y., & Mebs, D. 2003. Identification of Alpha-bungarotoxin (A31) as the Major Postsynaptic Neurotoxin, and Complete Nucleotide Identity of a Genomic DNA of Bungarus candidus from Java with Exons of the Bungarus multicinctus alpha-bungarotoxin (A31) Gene. Toxicon. 42:381-390.
Kuch, U., & Zug, G.R.2004. Bungarus candidus (Malayan Krait) Diet. Herpetological Review. 35: 274.
Kuhn, P., Deacon A. M., Comoso, S., Rajaseger, G., Manjunatha Kini, R., Uso`n, I., Kolatkar, P. R. 2000. The atomic resolution structure of bucandin, a novel toxin isolated from the Malayan krait, determined by direct methods. Acta Crystallographica. D56: 1401-1407.
Fry, B.G., Wuster, W., Kini,R.M., Brusic, V., Khan, A., Venkataraman, D.,& Rooney, A.P. 2003. Molecular Evolution and Phylogeny of Elapid Snake Venom and Three-Finger Toxins. Journal of Molecular Evolution. 57:110-129.
Khow, O. Chanhome, L., Omori-Satoh, T., Ogawa, Y., Yanoshita, R., Samejima, Y., Kuch, U., Mebs, D., & Sitprija, V. 2003. Isolation, Toxicity and Amino Terminal Sequences of Three Major Neurotoxins in the Venom of Malayan Krait (Bungarus candidus) from Thailand. Journal of Biochemistry.134: 799-804.
Kuch, U., Molles, B.E., Satoh, T.O., Chanhome, L., Samejima , Y., & Mebs, D. 2003. Identification of Alpha-bungarotoxin (A31) as the Major Postsynaptic Neurotoxin, and Complete Nucleotide Identity of a Genomic DNA of Bungarus candidus from Java with Exons of the Bungarus multicinctus alpha-bungarotoxin (A31) Gene. Toxicon. 42:381-390.
Kuch, U., & Zug, G.R.2004. Bungarus candidus (Malayan Krait) Diet. Herpetological Review. 35: 274.
Kuhn, P., Deacon A. M., Comoso, S., Rajaseger, G., Manjunatha Kini, R., Uso`n, I., Kolatkar, P. R. 2000. The atomic resolution structure of bucandin, a novel toxin isolated from the Malayan krait, determined by direct methods. Acta Crystallographica. D56: 1401-1407.
Sources (cont’d.)Sources (cont’d.)
Laothong, C., & Sitprija, V.2001. Decreased Parasympathetic Activities in Malayan Krait (Bungarus candidus) Envenoming.Toxicon.39:1353-1357.
Lewis, R. L. M.D., Gutmann, L. M.D. 2004. Snake Venoms and the Neuromuscular Junction: Presynaptic Inhibition. Semin Neurol. 24(2).
Nirthanan, S., Charpantier, E., Gopalakrishnakone, P., Gwee, M.C., Khoo, H.E., Cheah, L.S., Kini, R.M. & Bertrand, D. 2003. Neuromuscular Effects of Candoxin, a Novel Toxin from the Venom of the Malayan Krait (Bungarus candidus). British Journal of Pharmacology. 139:832-844.
Nirthanan, S., Charpantier, E., Gopalakrishnakone, P., Gwee, M.C., Khoo, H.E., Cheah, L.S., Bertrand, D., & Kini, R.M. 2002. Candoxin, a Novel Toxin from Bungarus candidus, Is a Reversible Antagonist of Muscle but a Poorly Reversible Antagonist of Neuronal Nicotinic Acetylcholine Receptors. The Journal of Biological Chemistry. 277: 17811-17820.
Nirthanan, S., Gopalakrishnakone, P., Gwee, M. C. E., Khoo, H. E. and Kini, R. M. 2002. Non-conventional toxins from elapid venoms. Toxicon, 41: 397-407.
Laothong, C., & Sitprija, V.2001. Decreased Parasympathetic Activities in Malayan Krait (Bungarus candidus) Envenoming.Toxicon.39:1353-1357.
Lewis, R. L. M.D., Gutmann, L. M.D. 2004. Snake Venoms and the Neuromuscular Junction: Presynaptic Inhibition. Semin Neurol. 24(2).
Nirthanan, S., Charpantier, E., Gopalakrishnakone, P., Gwee, M.C., Khoo, H.E., Cheah, L.S., Kini, R.M. & Bertrand, D. 2003. Neuromuscular Effects of Candoxin, a Novel Toxin from the Venom of the Malayan Krait (Bungarus candidus). British Journal of Pharmacology. 139:832-844.
Nirthanan, S., Charpantier, E., Gopalakrishnakone, P., Gwee, M.C., Khoo, H.E., Cheah, L.S., Bertrand, D., & Kini, R.M. 2002. Candoxin, a Novel Toxin from Bungarus candidus, Is a Reversible Antagonist of Muscle but a Poorly Reversible Antagonist of Neuronal Nicotinic Acetylcholine Receptors. The Journal of Biological Chemistry. 277: 17811-17820.
Nirthanan, S., Gopalakrishnakone, P., Gwee, M. C. E., Khoo, H. E. and Kini, R. M. 2002. Non-conventional toxins from elapid venoms. Toxicon, 41: 397-407.
Sources (cont’d.)Sources (cont’d.)
Nirthanan, S., Stanson, J.J., Ponnampalam, G., Eng, M.C., Khoo, H.E., & Kini, R.M. 2001. A Neurotoxin (Candoxin) Isolated from the Venom of the Malayan Krait Bungarus candidus, Significantly Potentiates the Activity of Acetylcholinesterase in the Venom. FASEB Journal. 15: 894-895
Shivaji, P.G. 2004. Snake Venom Neurotoxins: Pharmacological Classification. Toxin Reviews.23:37-96.
Tanh, N.H., Poh, C.H., & Tan, C.S. 1989. The Lethal and Biochemical Properties of Bungarus candidus (Malayan Krait) Venom and Venom Fractions. Toxicon. 27:1065-1070
Torres, A.M., Kini, R. M., Selvanayagam, N., & Kuchel, P.W. 2001. NMR Structure of Bucandin, a Neurotoxin from the Venom of the Malayan Krait (Bungarus candidus). Biochemical Society. 360:539-548.
Trinh, K.X., & Trinh, L.X. 2005.The Production of Bungarus candidus Antivenom from Horses Immunized with Venom & it’s Application for the Treatment of Snake Bite Patients in Vietnam. Therapeutic Drug Monitoring.27:230.
Nirthanan, S., Stanson, J.J., Ponnampalam, G., Eng, M.C., Khoo, H.E., & Kini, R.M. 2001. A Neurotoxin (Candoxin) Isolated from the Venom of the Malayan Krait Bungarus candidus, Significantly Potentiates the Activity of Acetylcholinesterase in the Venom. FASEB Journal. 15: 894-895
Shivaji, P.G. 2004. Snake Venom Neurotoxins: Pharmacological Classification. Toxin Reviews.23:37-96.
Tanh, N.H., Poh, C.H., & Tan, C.S. 1989. The Lethal and Biochemical Properties of Bungarus candidus (Malayan Krait) Venom and Venom Fractions. Toxicon. 27:1065-1070
Torres, A.M., Kini, R. M., Selvanayagam, N., & Kuchel, P.W. 2001. NMR Structure of Bucandin, a Neurotoxin from the Venom of the Malayan Krait (Bungarus candidus). Biochemical Society. 360:539-548.
Trinh, K.X., & Trinh, L.X. 2005.The Production of Bungarus candidus Antivenom from Horses Immunized with Venom & it’s Application for the Treatment of Snake Bite Patients in Vietnam. Therapeutic Drug Monitoring.27:230.
Sources (cont’d.)
Warrel, D.A., Looareesuwan, S., White, N.J., Theakston, R.G., Warrell, M.J., Kosakarn, W., & Reid, H.A.1983. Severe Neurotoxic Envenoming by the Malayan Krait Bungarus candidus- Response to Anti-venom and Anti-cholinesterase. British Medical Journal.286:678-680.Wirat, L., & Sming, K. 2007. Specific Antivenom for Bungarus candidus. Journal of the Medical Association of Thailand. 90:1467-1476.